GENOR-B (06998): Starting December 31st, the company's English and Chinese stock abbreviations will no longer be marked with a "B".

date
16:40 22/12/2025
avatar
GMT Eight
Jiahe Biotech-B (06998) has announced that, after applying to the Stock Exchange in accordance with Rule 18A.12 of the Listing Rules, the Stock Exchange has granted approval for Rules 18A.09 to 18A.11 (related rules) not to apply to the company, but it must be implemented after the completion of the merger.
GENOR-B (06998) Announcement: After submitting an application to the Stock Exchange in accordance with Rule 18A.12 of the Listing Rules, the Stock Exchange has approved that Rules 18A.09 to 18A.11 (related rules) do not apply to the company, but implementation is subject to completion of the merger. As the related rules do not apply and are pending completion of the merger on December 30, 2025 (the expected completion date disclosed in the circular), starting from December 31, 2025 (the first trading day following the completion date (as defined in the Listing Rules)), the English and Chinese stock abbreviations of the company will no longer bear the "B" designation. The stock code of the company will remain as "6998". Additionally, the company is in the process of proposing a change of company name and subsequently changing its stock abbreviation, and will issue a separate announcement on the effective date of the new stock abbreviation at an appropriate time.